Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Sommer T, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Jun 12. doi: 10.1002/clc.22996. [Epub ahead of print]

2.

Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Tabert H, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Apr;41(4):481-487. doi: 10.1002/clc.22900. Epub 2018 Apr 17.

3.

Identification of Periprocedural Myocardial Infarction Using a High-Sensitivity Troponin I Assay in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Liebetrau C, Kim WK, Meyer A, Arsalan M, Gaede L, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Dörr O, Schillinger S, Troidl C, Nef HM, Hamm CW, Walther T, Möllmann H.

Am J Cardiol. 2017 Oct 1;120(7):1180-1186. doi: 10.1016/j.amjcard.2017.06.069. Epub 2017 Jul 14.

PMID:
28826900
4.

Cardiac Myosin Binding Protein-C Autoantibodies are Potential Early Indicators of Cardiac Dysfunction and Patient Outcome in Acute Coronary Syndrome.

Lynch TL 4th, Kuster DWD, Gonzalez B, Balasubramanian N, Nair N, Day S, Calvino JE, Tan Y, Liebetrau C, Troidl C, Hamm CW, Güçlü A, McDonough B, Marian AJ, van der Velden J, Seidman CE, Huggins GS, Sadayappan S.

JACC Basic Transl Sci. 2017 Apr;2(2):122-131. doi: 10.1016/j.jacbts.2016.12.001. Epub 2016 Dec 19.

5.

Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y12 Receptor and Aggregation.

Gündüz D, Tanislav C, Sedding D, Parahuleva M, Santoso S, Troidl C, Hamm CW, Aslam M.

Int J Mol Sci. 2017 Jan 29;18(2). pii: E269. doi: 10.3390/ijms18020269.

6.

Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.

Lynch TL 4th, Ismahil MA, Jegga AG, Zilliox MJ, Troidl C, Prabhu SD, Sadayappan S.

J Mol Cell Cardiol. 2017 Jan;102:83-93. doi: 10.1016/j.yjmcc.2016.12.002. Epub 2016 Dec 10.

7.

Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction.

Liebetrau C, Gaede L, Wolter JS, Homann J, Meyer A, Dörr O, Nef HM, Troidl C, Hamm CW, Möllmann H, Richards AM, Pemberton CJ.

Biomarkers. 2017 May - Jun;22(3-4):304-310. doi: 10.1080/1354750X.2016.1252965. Epub 2016 Nov 22.

PMID:
27775442
8.

N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro.

Lipps C, Nguyen JH, Pyttel L, Lynch TL 4th, Liebetrau C, Aleshcheva G, Voss S, Dörr O, Nef HM, Möllmann H, Hamm CW, Sadayappan S, Troidl C.

J Mol Cell Cardiol. 2016 Oct;99:47-56. doi: 10.1016/j.yjmcc.2016.09.003. Epub 2016 Sep 8.

9.

Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice.

Kaur H, Takefuji M, Ngai CY, Carvalho J, Bayer J, Wietelmann A, Poetsch A, Hoelper S, Conway SJ, Möllmann H, Looso M, Troidl C, Offermanns S, Wettschureck N.

Circ Res. 2016 Jun 10;118(12):1906-17. doi: 10.1161/CIRCRESAHA.116.308643. Epub 2016 May 2. Erratum in: Circ Res. 2016 Sep 16;119(7):e109.

10.

Plasma microRNA-21 for the early prediction of acute kidney injury in patients undergoing major cardiac surgery.

Gaede L, Liebetrau C, Blumenstein J, Troidl C, Dörr O, Kim WK, Gottfried K, Voss S, Berkowitsch A, Walther T, Nef H, Hamm CW, Möllmann H.

Nephrol Dial Transplant. 2016 May;31(5):760-6. doi: 10.1093/ndt/gfw007. Epub 2016 Mar 2.

PMID:
26940124
11.

Effect of Renal Sympathetic Denervation on Specific MicroRNAs as an Indicator of Reverse Remodeling Processes in Hypertensive Heart Disease.

Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Lankes S, Guckel D, Boeder N, Voss S, Bauer T, Hamm C, Nef H.

J Clin Hypertens (Greenwich). 2016 Jun;18(6):497-502. doi: 10.1111/jch.12797. Epub 2016 Feb 24.

12.

Long-term verification of functional and structural renal damage after renal sympathetic denervation.

Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Wiebe J, Renker M, Bauer T, Hamm C, Nef H.

Catheter Cardiovasc Interv. 2016 Jun;87(7):1298-303. doi: 10.1002/ccd.26355. Epub 2015 Dec 23.

PMID:
26699846
13.

Reference Values and Release Kinetics of B-Type Natriuretic Peptide Signal Peptide in Patients with Acute Myocardial Infarction.

Liebetrau C, Gaede L, Dörr O, Blumenstein J, Rosenburg S, Hoffmann J, Troidl C, Hamm CW, Nef HM, Möllmann H, Richards AM, Pemberton CJ.

Clin Chem. 2015 Dec;61(12):1532-9. doi: 10.1373/clinchem.2015.244327. Epub 2015 Oct 27.

14.

New potential diagnostic biomarkers for pulmonary hypertension.

Tiede SL, Gall H, Dörr O, dos Santos Guilherme M, Troidl C, Liebetrau C, Voss S, Voswinckel R, Schermuly RT, Seeger W, Grimminger F, Zeiher AM, Dimmeler S, Möllmann H, Hamm CW, Ghofrani HA, Nef HM.

Eur Respir J. 2015 Nov;46(5):1390-6. doi: 10.1183/13993003.00187-2015. Epub 2015 Aug 6. Erratum in: Eur Respir J. 2016 Sep;48(3):962.

15.

Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation.

Dörr O, Ewen S, Liebetrau C, Möllmann H, Gaede L, Linz D, Hohl M, Troidl C, Bauer T, Böhm M, Hamm C, Mahfoud F, Nef H.

Clin Res Cardiol. 2015 Dec;104(12):1064-71. doi: 10.1007/s00392-015-0874-8. Epub 2015 May 26.

PMID:
26008896
16.

Ischemia and reperfusion related myocardial inflammation: A network of cells and mediators targeting the cardiomyocyte.

Rohrbach S, Troidl C, Hamm C, Schulz R.

IUBMB Life. 2015 Feb;67(2):110-9. doi: 10.1002/iub.1352. Epub 2015 Apr 8. Review.

17.

Brain-derived neurotrophic factor as a marker for immediate assessment of the success of renal sympathetic denervation.

Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Haidner V, Wiebe J, Voss S, Bauer T, Hamm C, Nef H.

J Am Coll Cardiol. 2015 Mar 24;65(11):1151-3. doi: 10.1016/j.jacc.2014.11.071. No abstract available.

18.

Influence of Renal Sympathetic Denervation on Cardiac Extracellular Matrix Turnover and Cardiac Fibrosis.

Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Morczeck K, Wiebe J, Hoffmann J, Voss S, Bauer T, Hamm C, Nef H.

Am J Hypertens. 2015 Oct;28(10):1285-92. doi: 10.1093/ajh/hpv020. Epub 2015 Mar 11.

PMID:
25767136
19.

Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.

Van Aelst LN, Voss S, Carai P, Van Leeuwen R, Vanhoutte D, Sanders-van Wijk S, Eurlings L, Swinnen M, Verheyen FK, Verbeken E, Nef H, Troidl C, Cook SA, Brunner-La Rocca HP, Möllmann H, Papageorgiou AP, Heymans S.

Circ Res. 2015 Jan 30;116(3):425-36. doi: 10.1161/CIRCRESAHA.116.304599. Epub 2014 Dec 17.

20.

Release kinetics of inflammatory biomarkers in a clinical model of acute myocardial infarction.

Liebetrau C, Hoffmann J, Dörr O, Gaede L, Blumenstein J, Biermann H, Pyttel L, Thiele P, Troidl C, Berkowitsch A, Rolf A, Voss S, Hamm CW, Nef H, Möllmann H.

Circ Res. 2015 Feb 27;116(5):867-75. doi: 10.1161/CIRCRESAHA.116.304653. Epub 2014 Dec 16.

21.

cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation.

Aslam M, Tanislav C, Troidl C, Schulz R, Hamm C, Gündüz D.

Physiol Rep. 2014 Oct 24;2(10). pii: e12175. doi: 10.14814/phy2.12175. Print 2014 Oct 1.

22.

Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension.

Dörr O, Liebetrau C, Möllmann H, Mahfoud F, Ewen S, Gaede L, Troidl C, Hoffmann J, Busch N, Laux G, Wiebe J, Bauer T, Hamm C, Nef H.

Clin Res Cardiol. 2015 Feb;104(2):175-84. doi: 10.1007/s00392-014-0773-4. Epub 2014 Oct 18.

PMID:
25326158
23.

Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis.

Sajjad A, Novoyatleva T, Vergarajauregui S, Troidl C, Schermuly RT, Tucker HO, Engel FB.

Biochim Biophys Acta. 2014 Nov;1843(11):2556-62. doi: 10.1016/j.bbamcr.2014.06.019. Epub 2014 Jul 8.

24.

Sham surgery and inter-individual heterogeneity are major determinants of monocyte subset kinetics in a mouse model of myocardial infarction.

Hoffmann J, Ospelt M, Troidl C, Voss S, Liebetrau C, Kim WK, Rolf A, Wietelmann A, Braun T, Troidl K, Sadayappan S, Barefield D, Hamm C, Nef H, Möllmann H.

PLoS One. 2014 Jun 3;9(6):e98456. doi: 10.1371/journal.pone.0098456. eCollection 2014.

25.

Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction.

Liebetrau C, Nef HM, Dörr O, Gaede L, Hoffmann J, Hahnel A, Rolf A, Troidl C, Lackner KJ, Keller T, Hamm CW, Möllmann H.

Heart. 2014 Apr;100(8):652-7. doi: 10.1136/heartjnl-2013-305253. Epub 2014 Jan 31.

PMID:
24488609
26.

Soluble fms-like tyrosine kinase-1 and endothelial adhesion molecules (intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1) as predictive markers for blood pressure reduction after renal sympathetic denervation.

Dörr O, Liebetrau C, Möllmann H, Gaede L, Troidl C, Rixe J, Hamm C, Nef H.

Hypertension. 2014 May;63(5):984-90. doi: 10.1161/HYPERTENSIONAHA.113.02266. Epub 2014 Jan 27.

27.

Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.

Kuster DW, Cardenas-Ospina A, Miller L, Liebetrau C, Troidl C, Nef HM, Möllmann H, Hamm CW, Pieper KS, Mahaffey KW, Kleiman NS, Stuyvers BD, Marian AJ, Sadayappan S.

Am J Physiol Heart Circ Physiol. 2014 Feb 15;306(4):H547-56. doi: 10.1152/ajpheart.00846.2013. Epub 2013 Dec 13.

28.

Reply: effects of heparin on temporal microRNA profiles.

Liebetrau C, Möllmann H, Troidl C, Nef H.

J Am Coll Cardiol. 2014 Mar 11;63(9):941-2. doi: 10.1016/j.jacc.2013.09.077. Epub 2013 Dec 4. No abstract available.

29.

Release kinetics of N-terminal pro-B-type natriuretic peptide in a clinical model of acute myocardial infarction.

Liebetrau C, Gaede L, Dörr O, Troidl C, Voss S, Hoffmann J, Paszko A, Weber M, Rolf A, Hamm C, Nef H, Möllmann H.

Clin Chim Acta. 2014 Feb 15;429:34-7. doi: 10.1016/j.cca.2013.11.017. Epub 2013 Dec 1.

PMID:
24291058
30.

Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy.

Liebetrau C, Möllmann H, Dörr O, Szardien S, Troidl C, Willmer M, Voss S, Gaede L, Rixe J, Rolf A, Hamm C, Nef H.

J Am Coll Cardiol. 2013 Sep 10;62(11):992-8. doi: 10.1016/j.jacc.2013.05.025. Epub 2013 Jun 7.

31.

Molecular basis of disturbed extracellular matrix homeostasis in stress cardiomyopathy.

Szardien S, Möllmann H, Willmer M, Liebetrau C, Voss S, Troidl C, Hoffmann J, Rixe J, Elsässer A, Hamm CW, Nef HM.

Int J Cardiol. 2013 Sep 30;168(2):1685-8. doi: 10.1016/j.ijcard.2013.03.075. Epub 2013 Apr 28. No abstract available.

PMID:
23632119
32.

Role of the phosphatase PTEN in early vascular remodeling.

Sedding DG, Widmer-Teske R, Mueller A, Stieger P, Daniel JM, Gündüz D, Pullamsetti S, Nef H, Moellmann H, Troidl C, Hamm C, Braun-Dullaeus R.

PLoS One. 2013;8(3):e55445. doi: 10.1371/journal.pone.0055445. Epub 2013 Mar 22.

33.

The temporal and spatial distribution of macrophage subpopulations during arteriogenesis.

Troidl C, Jung G, Troidl K, Hoffmann J, Mollmann H, Nef H, Schaper W, Hamm CW, Schmitz-Rixen T.

Curr Vasc Pharmacol. 2013 Jan;11(1):5-12.

PMID:
23391417
34.

Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy.

Shao Y, Redfors B, Scharin Täng M, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E.

Int J Cardiol. 2013 Oct 3;168(3):1943-50. doi: 10.1016/j.ijcard.2012.12.092. Epub 2013 Jan 26.

PMID:
23357048
35.

Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy.

Liebetrau C, Nef H, Szardien S, Dörr O, Willmer M, Voss S, Troidl C, Hoffmann J, Rixe J, Rolf A, Hamm C, Möllmann H.

Clin Chem. 2013 Mar;59(3):566-9. doi: 10.1373/clinchem.2012.194001. Epub 2013 Jan 3.

36.

Renal sympathetic denervation does not aggravate functional or structural renal damage.

Dörr O, Liebetrau C, Möllmann H, Achenbach S, Sedding D, Szardien S, Willmer M, Rixe J, Troidl C, Elsässer A, Hamm C, Nef HM.

J Am Coll Cardiol. 2013 Jan 29;61(4):479-80. doi: 10.1016/j.jacc.2012.09.051. Epub 2012 Dec 19. No abstract available.

37.

A mouse model reveals an important role for catecholamine-induced lipotoxicity in the pathogenesis of stress-induced cardiomyopathy.

Shao Y, Redfors B, Ståhlman M, Täng MS, Miljanovic A, Möllmann H, Troidl C, Szardien S, Hamm C, Nef H, Borén J, Omerovic E.

Eur J Heart Fail. 2013 Jan;15(1):9-22. doi: 10.1093/eurjhf/hfs161. Epub 2012 Oct 25.

38.

Bone marrow-derived cells contribute to cell turnover in aging murine hearts.

Szardien S, Nef HM, Troidl C, Willmer M, Voss S, Liebetrau C, Hoffmann J, Rolf A, Rixe J, Elsässer A, Hamm CW, Möllmann H.

Int J Mol Med. 2012 Aug;30(2):283-7. doi: 10.3892/ijmm.2012.995. Epub 2012 May 9.

PMID:
22580818
39.

Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy.

Liebetrau C, Möllmann H, Nef H, Szardien S, Rixe J, Troidl C, Willmer M, Hoffmann J, Weber M, Rolf A, Hamm C.

Clin Chem. 2012 Jun;58(6):1049-54. doi: 10.1373/clinchem.2011.178129. Epub 2012 Apr 13.

40.

Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1β synthesis.

Szardien S, Nef HM, Voss S, Troidl C, Liebetrau C, Hoffmann J, Rauch M, Mayer K, Kimmich K, Rolf A, Rixe J, Troidl K, Kojonazarov B, Schermuly RT, Kostin S, Elsässer A, Hamm CW, Möllmann H.

Eur Heart J. 2012 Mar;33(5):595-605. doi: 10.1093/eurheartj/ehr434. Epub 2011 Nov 21.

PMID:
22106340
41.

Cerebral arteriogenesis is enhanced by pharmacological as well as fluid-shear-stress activation of the Trpv4 calcium channel.

Schierling W, Troidl K, Apfelbeck H, Troidl C, Kasprzak PM, Schaper W, Schmitz-Rixen T.

Eur J Vasc Endovasc Surg. 2011 May;41(5):589-96. doi: 10.1016/j.ejvs.2010.11.034. Epub 2011 Feb 11.

42.

Transient elevation of NT-pro-BNP as a predictor for myocardial ischemia.

Szardien S, Nef HM, Möllmann H, Voss S, Troidl C, Liebetrau C, Rolf A, Rixe J, Weber M, Hamm CW.

Clin Res Cardiol. 2010 Dec;99(12):857-9. doi: 10.1007/s00392-010-0211-1. Epub 2010 Sep 7. No abstract available.

PMID:
20821018
43.

'Turning the right screw': targeting the interleukin-6 receptor to reduce unfavourable tissue remodelling after myocardial infarction.

Möllmann H, Nef HM, Troidl C.

Cardiovasc Res. 2010 Aug 1;87(3):395-6. doi: 10.1093/cvr/cvq186. Epub 2010 Jun 16. No abstract available.

PMID:
20558440
44.

Elevated serum levels of neuropeptide Y in stress cardiomyopathy.

Szardien S, Möllmann H, Voss S, Troidl C, Rolf A, Liebetrau C, Rixe J, Elsässer A, Hamm CW, Nef HM.

Int J Cardiol. 2011 Feb 17;147(1):155-7. doi: 10.1016/j.ijcard.2010.05.010. Epub 2010 Jun 16. No abstract available.

PMID:
20557961
45.

Calcium-dependent signalling is essential during collateral growth in the pig hind limb-ischemia model.

Troidl C, Nef H, Voss S, Schilp A, Kostin S, Troidl K, Szardien S, Rolf A, Schmitz-Rixen T, Schaper W, Hamm CW, Elsässer A, Möllmann H.

J Mol Cell Cardiol. 2010 Jul;49(1):142-51. doi: 10.1016/j.yjmcc.2010.03.021. Epub 2010 Apr 2.

PMID:
20363225
46.

Effects of endogenous nitric oxide and of DETA NONOate in arteriogenesis.

Troidl K, Tribulova S, Cai WJ, Rüding I, Apfelbeck H, Schierling W, Troidl C, Schmitz-Rixen T, Schaper W.

J Cardiovasc Pharmacol. 2010 Feb;55(2):153-60. doi: 10.1097/FJC.0b013e3181c9556f.

PMID:
20173509
47.

Desynchronization: a novel model to induce heart failure.

Möllmann H, Voss S, Nef HM, Lintz M, Oltenau C, Kostin S, Sperzel J, Troidl C, Skwara W, Rolf A, Hamm C, Elsässer A.

Thorac Cardiovasc Surg. 2009 Dec;57(8):441-8. doi: 10.1055/s-0029-1186070.

PMID:
20013615
48.

Stem cell-mediated natural tissue engineering.

Möllmann H, Nef HM, Voss S, Troidl C, Willmer M, Szardien S, Rolf A, Klement M, Voswinckel R, Kostin S, Ghofrani HA, Hamm CW, Elsässer A.

J Cell Mol Med. 2011 Jan;15(1):52-62. doi: 10.1111/j.1582-4934.2009.00972.x.

49.

Actin-binding rho activating protein (Abra) is essential for fluid shear stress-induced arteriogenesis.

Troidl K, Rüding I, Cai WJ, Mücke Y, Grossekettler L, Piotrowska I, Apfelbeck H, Schierling W, Volger OL, Horrevoets AJ, Grote K, Schmitz-Rixen T, Schaper W, Troidl C.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2093-101. doi: 10.1161/ATVBAHA.109.195305. Epub 2009 Sep 24. Erratum in: Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):e181.

50.

Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy.

Nef HM, Möllmann H, Hilpert P, Troidl C, Voss S, Rolf A, Behrens CB, Weber M, Hamm CW, Elsässer A.

Eur J Heart Fail. 2009 Aug;11(8):758-64. doi: 10.1093/eurjhf/hfp076.

Supplemental Content

Loading ...
Support Center